Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 5.90
+0.54 (10.07%)
Sep 10, 2026, 11:30 AM CST
SHA:600488 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,853 | 4,466 | 4,630 | 5,360 | 4,835 | 5,051 | |
Market Cap Growth | 24.94% | -3.54% | -13.63% | 10.87% | -4.27% | -6.93% |
Enterprise Value | 6,492 | 5,415 | 5,390 | 6,655 | 6,489 | 7,011 |
Last Close Price | 5.36 | 4.05 | 4.11 | 4.64 | 4.17 | 4.32 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 89.63 | 63.29 | 34.69 | 45.79 | 136.56 | 103.78 |
Forward PE | - | 70.80 | 70.80 | 70.80 | 70.80 | 70.80 |
PS Ratio | 2.22 | 1.54 | 1.44 | 1.42 | 1.31 | 1.35 |
PB Ratio | 1.52 | 1.15 | 1.19 | 1.43 | 1.29 | 1.32 |
P/TBV Ratio | 2.21 | 1.69 | 1.71 | 2.02 | 1.78 | 1.80 |
P/FCF Ratio | 22.57 | 55.43 | 9.42 | 8.25 | 10.71 | - |
P/OCF Ratio | 19.00 | 32.72 | 8.13 | 6.85 | 7.40 | 15.94 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.47 | 1.86 | 1.68 | 1.76 | 1.76 | 1.87 |
EV/EBITDA Ratio | 15.28 | 10.89 | 9.51 | 14.76 | 14.81 | 18.30 |
EV/EBIT Ratio | 46.66 | 26.07 | 19.96 | 36.99 | 35.78 | 39.35 |
EV/FCF Ratio | 25.04 | 67.21 | 10.96 | 10.24 | 14.38 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.18 | 0.18 | 0.14 | 0.25 | 0.37 | 0.37 |
Debt / EBITDA Ratio | 1.59 | 1.41 | 0.94 | 2.11 | 3.20 | 3.67 |
Debt / FCF Ratio | 2.61 | 8.73 | 1.09 | 1.47 | 3.11 | - |
Net Debt / Equity Ratio | -0.05 | -0.03 | -0.03 | 0.06 | 0.20 | 0.31 |
Net Debt / EBITDA Ratio | -0.43 | -0.24 | -0.18 | 0.52 | 1.72 | 3.07 |
Net Debt / FCF Ratio | -0.70 | -1.51 | -0.21 | 0.36 | 1.67 | -21.78 |
Asset Turnover | 0.45 | 0.51 | 0.54 | 0.59 | 0.57 | 0.60 |
Inventory Turnover | 2.58 | 2.92 | 2.61 | 2.21 | 1.81 | 1.94 |
Quick Ratio | 1.02 | 1.36 | 0.92 | 0.68 | 0.51 | 0.43 |
Current Ratio | 1.41 | 1.88 | 1.49 | 1.09 | 1.03 | 0.93 |
Return on Equity (ROE) | 2.31% | 3.14% | 5.45% | 4.33% | 0.49% | 2.86% |
Return on Assets (ROA) | 1.50% | 2.27% | 2.85% | 1.76% | 1.74% | 1.78% |
Return on Invested Capital (ROIC) | 3.68% | 5.50% | 6.39% | 4.10% | 3.82% | 2.65% |
Return on Capital Employed (ROCE) | 3.40% | 4.50% | 6.00% | 4.30% | 4.10% | 4.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.10% | 1.58% | 2.88% | 2.18% | 0.73% | 0.96% |
FCF Yield | 4.43% | 1.80% | 10.62% | 12.12% | 9.34% | -1.07% |
Dividend Yield | 1.00% | 1.28% | 2.38% | 1.88% | 0.24% | 0.32% |
Payout Ratio | 85.40% | 180.04% | 92.45% | 40.80% | 170.19% | 119.63% |
Buyback Yield / Dilution | 1.64% | 0.75% | 0.01% | 1.13% | -2.31% | 1.33% |
Total Shareholder Return | 2.64% | 2.04% | 2.39% | 3.00% | -2.07% | 1.65% |